Moravia launches life sciences innovation initiative

A new, targeted program supports global growth of medical device and pharma companies.

Newbury Park, Calif – A new program from Moravia offers life sciences companies the right prescription for maximizing global growth opportunities.

Moravia has launched the Life Sciences Innovation Initiative (LSI), a customized program to promote globalization best practices among medical device manufacturers, pharma companies and other healthcare businesses.

Led by Li Murty, director of global life sciences programs for Moravia, the LSI program includes dedicated teams of globalization professionals who are specially trained to support life sciences clients, in addition to customized materials and procedures to address healthcare-specific issues.

“Healthcare companies have unique globalization challenges that can’t be served with a cookie-cutter approach,” Murty said. “International and country-specific compliance regulations, complex medical terminologies, wellness and safety issues, and a host of other healthcare concerns can’t be satisfied with business-as-usual services. We’ve created the LSI program to address the industry’s specific needs.”

Key components of the program include:

Best practices based on Moravia’s years of serving Fortune 100 companies;

Proprietary technology solutions with plug-ins customized for life sciences companies, such as audit trail capabilities and automated QA tools incorporating the client's standard operating procedures (SOPs) or project-specific work instructions;

Objective analysis and counsel to optimize the role of globalization in future growth

“Since Moravia is technology agnostic, our only goal is to maximize our clients’ ROI,” Murty said. “Our LSI program isn’t about technology; it’s about achieving business excellence in all aspects of globalization to help drive profitable and long-term growth for healthcare companies.”